US 9878992
GDF-8 inhibitors
granted A61PA61P1/14A61P11/00
Quick answer
US patent 9878992 (GDF-8 inhibitors) held by Rigel Pharmaceuticals, Inc. expires Mon Jan 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rigel Pharmaceuticals, Inc.
- Grant date
- Tue Jan 30 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 2
- CPC classes
- A61P, A61P1/14, A61P11/00, A61P15/00, A61P19/08